Barclays Increases Encompass Health (NYSE:EHC) Price Target to $116.00

Encompass Health (NYSE:EHC - Free Report) had its price target raised by Barclays from $109.00 to $116.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other equities analysts also recently issued reports on EHC. Truist Financial increased their price objective on Encompass Health from $104.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, October 14th. UBS Group increased their target price on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, September 25th. Stephens reissued an "overweight" rating and issued a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. KeyCorp increased their target price on Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research note on Tuesday. Finally, Royal Bank of Canada increased their price objective on Encompass Health from $95.00 to $105.00 and gave the company an "outperform" rating in a research report on Thursday, September 26th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $105.67.

Encompass Health Trading Up 7.4 %

Shares of Encompass Health stock traded up $6.87 during midday trading on Tuesday, reaching $99.96. 2,378,365 shares of the company's stock traded hands, compared to its average volume of 636,316. The stock has a 50 day moving average of $93.67 and a 200-day moving average of $88.39. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market cap of $10.06 billion, a PE ratio of 24.14, a price-to-earnings-growth ratio of 1.45 and a beta of 0.88. Encompass Health has a 12 month low of $59.57 and a 12 month high of $102.36.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The firm's quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.86 earnings per share. As a group, equities analysts expect that Encompass Health will post 4.18 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.68%. Encompass Health's payout ratio is 16.43%.

Encompass Health declared that its Board of Directors has initiated a stock repurchase program on Wednesday, July 24th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 5.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board believes its stock is undervalued.

Insiders Place Their Bets

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the firm's stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the transaction, the chief financial officer now directly owns 136,227 shares of the company's stock, valued at approximately $11,761,839.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.10% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in EHC. State of Michigan Retirement System raised its stake in shares of Encompass Health by 2.5% in the first quarter. State of Michigan Retirement System now owns 24,645 shares of the company's stock worth $2,035,000 after buying an additional 600 shares during the period. State of Alaska Department of Revenue raised its stake in shares of Encompass Health by 11.5% in the first quarter. State of Alaska Department of Revenue now owns 12,076 shares of the company's stock worth $997,000 after buying an additional 1,250 shares during the period. Legacy Wealth Asset Management LLC raised its stake in shares of Encompass Health by 1.5% in the first quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company's stock worth $712,000 after buying an additional 130 shares during the period. Smith Group Asset Management LLC raised its stake in Encompass Health by 1.2% during the 1st quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company's stock valued at $997,000 after purchasing an additional 140 shares during the period. Finally, BNP Paribas Financial Markets lifted its holdings in Encompass Health by 57.5% in the 1st quarter. BNP Paribas Financial Markets now owns 30,313 shares of the company's stock worth $2,503,000 after purchasing an additional 11,070 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.